IFP Advisors, Inc - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$51,708
+25.4%
300
-50.0%
0.00%
+100.0%
Q2 2023$41,247
+287.0%
600
+100.0%
0.00%
Q1 2023$10,659
+88725.0%
300
-6.5%
0.00%
Q4 2022$12
-99.9%
321
-24.1%
0.00%
Q3 2022$19,0000.0%4230.0%0.00%
-100.0%
Q2 2022$19,000
-36.7%
423
-41.5%
0.00%
Q1 2022$30,000
+275.0%
723
+141.0%
0.00%
Q4 2021$8,000
+60.0%
300
+500.0%
0.00%
Q3 2021$5,000
-28.6%
500.0%0.00%
Q2 2021$7,000
+40.0%
500.0%0.00%
Q1 2021$5,000
-16.7%
500.0%0.00%
Q4 2020$6,000
+20.0%
500.0%0.00%
Q3 2020$5,000500.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders